What Form Does Zepbound Come In?
Zepbound (tirzepatide) is an injection, not a pill. It's administered as a weekly subcutaneous injection using a single-dose pen or vial.[1]
How Is Zepbound Injected?
Patients inject it under the skin in the abdomen, thigh, or upper arm once weekly. The starting dose is 2.5 mg, increasing gradually to a maximum of 15 mg based on tolerance and response.[1]
Is There an Oral Version of Zepbound?
No oral pill form exists. Zepbound is only available as an injectable. Eli Lilly, its manufacturer, has no approved oral tirzepatide product.[1]
How Does Zepbound Compare to Oral Weight Loss Drugs?
Unlike injectables like Zepbound or Wegovy, oral options like phentermine or orlistat are daily pills but generally less effective for significant weight loss. Zepbound's trials showed 15-21% average weight reduction over 72 weeks, outperforming most orals.[2][1]
Who Makes Zepbound and What's Its Approval Status?
Eli Lilly developed and markets Zepbound, FDA-approved in November 2023 for chronic weight management in adults with obesity or overweight plus related conditions.[1]
[1]: FDA Label for Zepbound
[2]: NEJM Tirzepatide Trial